Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer
More than 100,000 potential plaintiffs' fates will hinge on the outcome of four Zantac cancer bellwether trials next year
Tuesday, July 5, 2022 - The Zantac cancer litigation that parallels more than 125,000 registered plaintiffs in New Jersey multidistrict litigation (MDL), is picking up momentum as an Oakland California judge has set the first trial to begin early next year. Judge Evelio M. Grillo for the California Superior Court of Alameda County told reporters that the first Zantac ranitidine cancer trial will start on February 13, 2023. This is shortly after hearings are held in the California Zantac Judicial Council Coordination Proceedings, to decide on which scientific experts each side will be allowed to testify. The heartburn medicine cancer trial has special significance and will join several others as a bellwether of what may be expected from juries that hear all of the evidence. The second, third, and fourth bellwether trials in California are scheduled for May 1, August 7, and October 23, 2023, respectively. As a whole, a decisive victory by the plaintiff could encourage the defendants, Boehringer Ingelheim, Sanofi, Pfizer, and GlaxoSmithKline, to make a global settlement offer as other companies that faced billions in legal liability have done. The attorneys representing Zantac cancer plaintiffs in the initial bellwether trial have experience as having garnered more than $2billion in punitive damage awards against Monsanto/Bayer for causing cancer in users of Roundup herbicide. According to GlobalNewsWire.com, "Thousands of people suffering from cancer after taking Zantac have been waiting and waiting to have their day in court," says attorney R. Brent Wisner. "It is nice to be able to tell our clients that the litigation is picking up some steam and that we will soon be able to show a jury that the makers of Zantac knew as far back as the early 1980s that the drug can cause cancer. They need to be held accountable for putting profit over people." People that suffer from cancer of the bladder, stomach, esophageal or other forms of cancer and have taken Zantac heartburn and acid reflux medicine regularly continue to file lawsuits seeking to hold the manufacturers accountable. If you think you may have been injured by taking Zantac you should speak with a Zantac cancer lawyer immediately as there is limited time to file a claim.
Zantac heartburn and acid reflux medicine, made from ranitidine, was once a best-selling brand and had more than 15 million American customers when it was suddenly recalled. Online drug testing laboratory Valisure found thousands of times more N-nitrosodimethylamine (NDMA) than the 96 nanograms that the Food and Drug Administration (FDA) thought is safe. The company sent a citizen's petition to the FDA requesting the recall and the FDA complied. FDA tests, however, failed to confirm the extremely elevated levels of NDMA and have inferred that Valisure may have caused the spike by overheating test samples. The FDA issued the recall, however, out of an abundance of caution being unable to control or monitor shipping and storage temperatures for the drug.
More Recent Heartburn MedicineLawsuit News:
- Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
- Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
- The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
- Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
- Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.